At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Patent # | Description |
---|---|
US-9,631,000 |
Polynucleotides and polypeptides involved in plant fiber development and
methods of using same Isolated polynucleotides are provided. Each of the isolated polynucleotides comprise a nucleic acid sequence encoding a polypeptide having an amino acid... |
US-9,630,999 |
Use of Salmonella flagellin derivative in preparation of drug for
preventing and treating inflammatory bowel... The application of flagellin derivative CZLC31 from Salmonella in preparation of medicines for preventing and treating inflammatory bowel disease (IBD) is... |
US-9,630,998 |
Recombinant bacterial lipocalin Blc and uses thereof The present inventors have solved the crystal structure of an Escherichia coli bacterial lipocalin polypeptide, which depicts a monomeric protein. Previous... |
US-9,630,997 |
Compositions and methods for peptide expression and purification using a
type III secretion system Disclosed are compositions and methods for expressing and purifying a peptide of interest using a Flagellar Type III secretion system. Disclosed are nucleic... |
US-9,630,995 |
Method of improving immune function in HIV-infected subjects on HAART by
administering HIV-1 TAT Native Tat, when administered to patients with HIV infection, or who are otherwise immunocompromised, is capable of restoring immune functions so as to... |
US-9,630,994 |
Polypeptides for use in self-assembling protein nanostructures Synthetic nanostructures, polypeptides that are useful, for example, in making synthetic nanostructures, and methods for using such synthetic nanostructures are... |
US-9,630,993 |
HER2Delta16 peptides The present invention provides cyclic peptides comprising a dimer of peptides, each peptide comprising a sequence corresponding to the HER2 splice variant... |
US-9,630,989 |
Dipeptide analogs for treating conditions associated with amyloid fibril
formation Dipeptide analogs comprising a tryptophan (Trp) moiety coupled to a beta-sheet breaker moiety derived from alpha-aminoisobutyric acid (Aib) are disclosed. The... |
US-9,630,984 |
Compound contained in manuka honey and use of same The present description discloses a novel biologically active ingredient of manuka honey. Specially, the present description discloses a compound represented by... |
US-9,630,983 |
Organic electroluminescent material and devices Novel organic compounds containing a twisted aryl group are provided. In particular, the compounds provided contain a 2-phenylpyridine ligand having a twisted... |
US-9,630,977 |
Cephalosporin derivatives and pharmaceutical compositions thereof The present invention relates to novel cephalosporin derivatives represented by ##STR00001## X, Y, L, R1, and R2 are as same as defined in the description of... |
US-9,630,971 |
Free base crystals The present invention relates to crystals of (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluor- ... |
US-9,630,970 |
TYK2 inhibitors and uses thereof The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated... |
US-9,630,969 |
N-alkyl tryptanthrin derivative, preparation method for same, and
application thereof An N-alkyl tryptanthrin derivative, a preparation method for same, and an application thereof are provided. The structure of the derivative is as represented by... |
US-9,630,965 |
Fused amino pyridine as HSP90 inhibitors The present invention relates to HSP90 inhibitors containing fused amino pyridine core that are useful as inhibitors of HSP90 and their use in the treatment of... |
US-9,630,961 |
Arginine methyltransferase inhibitors and uses thereof Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein... |
US-9,630,958 |
Triazine compounds The present invention relates to novel triazine compounds of formula (1). The present invention also discloses compounds of formula I along with other... |
US-9,630,957 |
2,3-butanediamide epoxide compound and preparation method and use thereof Provided are a compound of formula I which can be used as a drug against small RNA virus infections, and optical isomers, pharmaceutically acceptable salts,... |
US-9,630,955 |
Chemical compound useful as intermediate for preparing a
catechol-O-methyltransferase inhibitor There is disclosed a methylated intermediate which may be demethylated to provide an inhibitor of catechol-O-methyltransferase useful in the treatment of... |
US-9,630,954 |
TCR/MHCII-collagen interaction inhibitors useful for treatment of
rheumatoid arthritis The T cells specific to human collagen type II, one of the possible autoantigens, have a crucial role in the development of rheumatoid arthritis in the context... |
US-9,630,952 |
Crystalline forms of afatinib di-maleate The present disclosure encompasses crystalline forms of Afatininb di-maleate and methods of their use. |
US-9,630,949 |
Oxoazetidine derivatives, process for the preparation thereof and use
thereof in human medicine and in cosmetics The present invention relates to novel compounds derived from oxoazetidine corresponding to general formula (I) to the compositions containing same, to the... |
US-9,630,948 |
Compounds for enhancing the cognitive function The invention relates to 2-oxo-1-pyrrolidinyl triazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as... |
US-9,630,947 |
Therapeutic compounds and related methods of use Methods of treating disorders using compounds that modulate striatal-enriched tyrosine phosphatase (STEP), such as those of formula (III), and composition... |
US-9,630,946 |
Maleate salts of
(E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quin-
... The present invention relates to maleate salt forms of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quin- ... |
US-9,630,943 |
Tetrahydronaphthyl(thio) carboxamides The present invention relates to novel tetrahydronaphthyl(thio) carboxamides, to processes for preparing these compounds, to compositions comprising these... |
US-9,630,939 |
Derivative of homoserine lactone, and preparation method and use thereof A derivative of homoserine lactone represented by formula I, and a preparation method and use thereof. The compound has a bacterial quorum-sensing regulatory... |
US-9,630,932 |
Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase
inhibitors The present invention provides trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitor compounds of formula (I), which may be... |
US-9,630,930 |
Diketopiperazine microparticles with defined specific surface areas Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m.sup.2/g. The diketopiperazine microparticle can be... |
US-9,630,929 |
Benzenesulfonamide compounds and their use as therapeutic agents This invention is directed to benzensulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable... |
US-9,630,927 |
Method and manufacturing system A method is provided. The method includes: assigning a buffer to a first wafer lot comprising a plurality of wafers according to a first trigger event... |
US-9,630,926 |
Bendamustine derivatives and methods of using same The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer. |
US-9,630,925 |
HSP90 inhibitor and preparation method and use thereof Disclosed are an Hsp90 inhibitor and a preparation method and use thereof. The Hsp90 inhibitor is ... |
US-9,630,924 |
Heterocyclic compound The present invention provides a heterocyclic compound having a ROR.gamma.t inhibitory action. The present invention relates to a compound represented by the... |
US-9,630,921 |
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase
inhibitors Compounds of the formula (I) useful as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors ##STR00001## |
US-9,630,920 |
Industrial methods for producing arylsulfur pentafluorides Industrial methods for producing arylsulfur pentafluorides are disclosed. Methods include reacting arylsulfur halotetrafluoride with hydrogen fluoride in the... |
US-9,630,919 |
Industrial methods for producing arylsulfur pentafluorides Industrial methods for producing arylsulfur pentafluorides are disclosed. Methods include reacting arylsulfur halotetrafluoride with hydrogen fluoride in the... |
US-9,630,918 |
Cysteine, N-acetylcysteine, and penicillamine related compounds,
pharmaceutical compositions thereof, and... Cysteine, N-acetylcysteine, and penicillamine related compounds, pharmaceutical compositions comprising the cysteine, N-acetylcysteine, and penicillamine... |
US-9,630,917 |
Cysteamine prodrugs, pharmaceutical compositions thereof, and methods of
use Cysteamine prodrugs, pharmaceutical compositions comprising the cysteamine prodrugs, and methods of using cysteamine prodrugs and pharmaceutical compositions... |
US-9,630,913 |
Nitro-containing bisoxime ester photoinitiator and preparation method and
use thereof This present invention discloses a nitro-containing bisoxime ester photoinitiator having a structure represented by general formula (I). This photoinitiator has... |
US-9,630,910 |
Pesticidal compositions and processes related thereto This document discloses molecules having the following formula ("Formula One"): ##STR00001## and processes associated therewith. |
US-9,630,905 |
Amphiphilic macromolecules and methods of use thereof Certain embodiments of the invention provide a compound of formula (I): A-X--Y--Z--R.sub.1 (I), or a salt thereof, wherein A, X, Y, Z and R.sub.1 have any of... |
US-9,630,903 |
Process for preparing and separating monodisperse polyethylene glycol A process for preparing and separating a monodisperse polyethylene glycol, including: dissolving a starting material of polyethylene glycol into an organic... |
US-9,630,901 |
Poly(acrylic acid) from bio-based acrylic acid and its derivatives Bio-based glacial acrylic acid, produced from hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof and having impurities of... |
US-9,630,896 |
2,5-dialkyl-4-H/halo/ether-phenol compounds The present disclosure provides phenolic compounds useful in the treatment of neurological conditions such as convulsions and tremors, having the structure of... |
US-9,630,892 |
Method for converting hydrocarbon feedstocks by means of thermal steam
cracking The invention relates to a process for converting hydrocarbon feeds by thermal steamcracking to at least one olefin-containing product stream comprising at... |
US-9,630,883 |
Ceramic composite material consisting of aluminium oxide and zirconium
oxide as the main constituents, and a... A composite material consisting of aluminium oxide as a ceramic matrix and zirconium oxide dispersed therein. A method for the production thereof, components... |
US-9,630,880 |
Cement/aggregate composition, concrete product and method for making a
concrete product A concrete product is produced by providing red dune sand having a particle size of 45 microns or less and mixing the red dune sand with hydraulic cement in a... |
US-9,630,878 |
Cementitious binders containing pozzolanic materials A cementitious composition including: a binder containing (a) 60-94%, by weight, of at least one pozzolanic material; (b) at least 0.5% calcium sulfoaluminate... |
US-9,630,874 |
Glass sheet with a high level of infrared radiation transmission The invention relates to a glass sheet with a high level of infrared radiation transmission, that can be used especially in a tactile tablet, panel or screen.... |